CymaBay Therapeutics

North America Legal Chronicle. February 28, 2024

Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics

By Leila Ahmed

Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Fidelity Bank’s Conversion and $198.4 Million Stock Offering

CECO Environmental’s $125 Million Acquisition of Profire Energy

Arcus Health Services’ Acquisitions of Personal Care Services Providers

Grupo Cohen’s US$8,9 Million Notes Issuance

Paramérica’s US$1.98 Million Notes Issuance

Opea Securitizadora’s R$100 Million Agribusiness Certificate Receivables Issuance

Werfen’s Acquisition of Omixon Biocomputing

Avignon Capital’s Refinancing Of Two Dutch Assets

DigitalBridge’s Acquisition Of Yondr Group

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

TVF Varlik Kiralama (Turkey Wealth Fund)’s $750 Million Sukuk Issuance

ROSHN’s SAR 9 Billion Syndicated Credit Facility

Fimi Opportunity Fund’s Acquisition of Maroom Dolphin

KEFTS’ LNG Sale and Purchase Agreement with Oman Liquefied Natural Gas

Ping An’s $850 Million Overseas’ Private Equity Fund

Project Ulysses’ Project Financing

Morrison Foerster Expands Capital Markets Footprint on the West Coast with Addition of Partner H. Thomas Felix, III in San Diego

Seyfarth Launches Energy Transactions Practice With Addition of Three-Lawyer Team in Houston

Cleary Gottlieb Continues Bay Area Expansion With Addition of Matthew Yelovich, Criminal Division Deputy Chief and Former Appellate Chief in California

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Morrison Foerster Expands Capital Markets Footprint on the West Coast with Addition of Partner H. Thomas Felix, III in San Diego

Seyfarth Launches Energy Transactions Practice With Addition of Three-Lawyer Team in Houston

Cleary Gottlieb Continues Bay Area Expansion With Addition of Matthew Yelovich, Criminal Division Deputy Chief and Former Appellate Chief in California

Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics

Standard 1 Year Membership Required